Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is > 10% Shareholder of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 1.73 Million shares of OLMA, which is worth approximately $15.4 Million. The most recent transaction as insider was on Nov 23, 2020, when has been sold 1,725,406 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.73M
0% 3M change
0% 12M change
Total Value Held $15.4 Million

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 23 2020
BUY
Conversion of derivative security
-
1,725,406 Added 50.0%
1,725,406 Common Stock

Also insider at

VERV
Verve Therapeutics, Inc. Healthcare
NUVL
Nuvalent, Inc. Healthcare
EWTX
Edgewise Therapeutics, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
RTVA
Artiva Biotherapeutics, Inc.
ACRV
Acrivon Therapeutics, Inc.
BOLD
Boundless Bio, Inc.
ZBIO
Zenas BioPharma, Inc.
WBI

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on OLMA

Follow Olema Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA